Your session is about to expire
← Back to Search
PRP vs Corticosteroids for Basal Joint Osteoarthritis
Study Summary
This trial is testing whether or not a type of blood injection called PRP is more effective than a corticosteroid for treating arthritis in the basal joint.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My thumb joint arthritis is severe (Stage 4).I have Pressier disease, Kienbock's, or avascular necrosis of the scaphoid.You are pregnant or have a terminal illness.My arthritis in the thumb joint is at an early to moderate stage.I have fibromyalgia or an inflammatory rheumatic disease.I've had a corticosteroid injection in my thumb joint within the last year.I have arthritis in specific wrist joints.I have or was treated for wrist tendon issues in the last 3 months.I have had a bone tumor in the past.I am being checked for nerve pain in my neck.
- Group 1: Normal Saline
- Group 2: Corticosteroid
- Group 3: PRP
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many volunteers have enrolled in this clinical experiment?
"Affirmative. The information hosted on clinicaltrials.gov indicates that this experiment, which was initially published on September 1st 2018, is currently recruiting subjects. Approximately 150 individuals need to be enrolled from one medical facility."
Is the enrollment of participants still open for this clinical trial?
"Affirmative. According to the details found on clinicaltrials.gov, this investigation is still enrolling volunteers. This study was first published in September 2018 and recently updated in December 2022; it requires 150 participants from a single site."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger